Novel plasmid-mediated beta-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy beta-lactams in clinical isolates of Klebsiella pneumoniae
about
Plasmid-determined AmpC-type beta-lactamases.Sequence of the MIR-1 beta-lactamase genebeta-Lactamases in laboratory and clinical resistanceA functional classification scheme for beta-lactamases and its correlation with molecular structureAmino acid sequence determinants of extended spectrum cephalosporin hydrolysis by the class C P99 beta-lactamase.Molecular characterization of cefoxitin-resistant Escherichia coli from Canadian hospitalsCharacterization of FOX-3, an AmpC-type plasmid-mediated beta-lactamase from an Italian isolate of Klebsiella oxytocabeta-Lactamases responsible for resistance to expanded-spectrum cephalosporins in Klebsiella pneumoniae, Escherichia coli, and Proteus mirabilis isolates recovered in South Africa.Outer membrane profiles of clonally related Klebsiella pneumoniae isolates from clinical samples and activities of cephalosporins and carbapenems.Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli isolates producing TEM-10 and TEM-43 beta-lactamases from St. Louis, MissouriMolecular characterization of an enterobacterial metallo beta-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistanceGene sequence and biochemical characterization of FOX-1 from Klebsiella pneumoniae, a new AmpC-type plasmid-mediated beta-lactamase with two molecular variants.Spread of a Klebsiella pneumoniae strain producing a plasmid-mediated ACC-1 AmpC beta-lactamase in a teaching hospital admitting disabled patients.The microbial genetics of antibiotic cycling.Practical methods using boronic acid compounds for identification of class C beta-lactamase-producing Klebsiella pneumoniae and Escherichia coliEfficacy of cefepime and imipenem in experimental murine pneumonia caused by porin-deficient Klebsiella pneumoniae producing CMY-2 beta-Lactamase.Occurrence and detection of AmpC beta-lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a veterans medical center.Dissemination of CTX-M-3 and CMY-2 beta-lactamases among clinical isolates of Escherichia coli in southern Taiwan.Use of microdilution panels with and without beta-lactamase inhibitors as a phenotypic test for beta-lactamase production among Escherichia coli, Klebsiella spp., Enterobacter spp., Citrobacter freundii, and Serratia marcescens.Roles of beta-lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniaeA novel type of AmpC beta-lactamase, ACC-1, produced by a Klebsiella pneumoniae strain causing nosocomial pneumoniaIBC-1, a novel integron-associated class A beta-lactamase with extended-spectrum properties produced by an Enterobacter cloacae clinical strain.Cloning and biochemical characterization of FOX-5, an AmpC-type plasmid-encoded beta-lactamase from a New York City Klebsiella pneumoniae clinical isolate.Evaluation of beta-lactamase inhibitors in disk tests for detection of plasmid-mediated AmpC beta-lactamases in well-characterized clinical strains of Klebsiella sppOrigin and evolution of the AmpC beta-lactamases of Citrobacter freundii.New beta-lactamases in gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy.Controversies about extended-spectrum and AmpC beta-lactamases.Extended-spectrum beta-lactamases: epidemiology, detection, and treatment.Beta-lactamase nomenclature.Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species: risk factors for colonization and impact of antimicrobial formulary interventions on colonization prevalence.Plasmid-borne AmpC beta-lactamases.In vitro selection of ramR and soxR mutants overexpressing efflux systems by fluoroquinolones as well as cefoxitin in Klebsiella pneumoniaePrevalence of newer beta-lactamases in gram-negative clinical isolates collected in the United States from 2001 to 2002Development of test panel of beta-lactamases expressed in a common Escherichia coli host background for evaluation of new beta-lactam antibioticsPlasmid-mediated dissemination of the metallo-beta-lactamase gene blaIMP among clinically isolated strains of Serratia marcescens.Characterization of the plasmidic beta-lactamase CMY-2, which is responsible for cephamycin resistance.In vivo selection of porin-deficient mutants of Klebsiella pneumoniae with increased resistance to cefoxitin and expanded-spectrum-cephalosporins.Transferable cefoxitin resistance in enterobacteria from Greek hospitals and characterization of a plasmid-mediated group 1 beta-lactamase (LAT-2).Comparative evaluation of the inhibitory activities of the novel penicillanic acid sulfone Ro 48-1220 against beta-lactamases that belong to groups 1, 2b, and 2be.Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the foss of an outer membrane protein.
P2860
Q24535748-C9FE4067-70C5-4213-95A0-B951DE4F6ED9Q24550644-6D45C8A8-6F0C-43E3-BC97-84E1306B8721Q24669605-4E719710-26E5-4944-9034-B1D266420414Q24677460-DDA86E4F-F795-4DB0-BDF6-D1687D1606BDQ30731622-8B11E9CC-A6BB-4905-A3C0-D082620BE422Q33554703-86E0AA7D-E0D5-4A44-AD80-ED882297240AQ33690231-6D55BC84-8FA6-4BAA-9825-D505EFEB9293Q33693251-9B0AA220-A8FD-4792-AE8A-51403CEC05B3Q33694016-23EFC2E7-8F55-4040-8D30-2F4436A3A24BQ33694083-C7CBCA97-EC04-487D-A745-F35385FEB12DQ33747222-5BA41C5A-373E-4A47-A719-08627133C310Q33759195-983F723A-B9C0-4D0F-918C-7CDBAFC3C8F2Q33770088-08D388B8-4CD4-4DD0-963C-B03E7022A8CFQ33827956-44942471-D1AA-409C-B5C6-0F0608C73E2FQ33856282-3D329005-B0EE-44B8-9EE4-90C18D12A895Q33938172-9ACC7DEE-52D1-4682-BAE7-43CB568646B6Q33966850-140367A7-BD37-4A19-B6EF-3D1C89F5113AQ33970463-2E920CC9-894E-4850-89AF-5C7EB564F459Q33976916-F486E0EE-6472-45CF-8159-AEB072EF00A0Q33977146-317D91A8-FE2A-4E03-9F86-ABB81CAFDBBEQ33977370-034E3819-4EAC-43E7-A95D-043E783C755AQ33980369-D7E098DF-B901-459C-8C7C-9257490DDDF5Q33983391-16115F03-D21B-4B59-B1A5-9A21223CA782Q34041616-24FDF840-65EB-406F-B84B-72F6C92126EFQ34107174-C06857AF-59CA-4DBF-A387-F6A4591C238BQ34192597-9F1A4DA5-16D2-4392-9DEB-ED0BD0677A21Q34213755-A635612D-8344-426C-9C47-B4791BA5AB50Q34445641-D810E0DB-337D-4B80-89E0-0CB4809BA09EQ34510623-CB2786DC-F2B5-413A-8241-153569C8BD44Q34652460-C012A0C4-47BC-4787-BE4F-7906507EAAF5Q34776284-D46270D5-EDB0-466C-AB59-90C3BC485C61Q35004824-726A4B82-C3E4-4E8E-980F-FF402819E18BQ35073335-871CB881-2930-492D-B477-18779551748FQ35111391-42D0C986-11C9-4E0D-B897-24769290FFACQ35112955-BCD075AD-2D05-40A8-9613-91076D9821ACQ35122028-5596A644-7A1F-4F47-8918-A9AF0CECD3F1Q35122321-87D8A962-3A78-40A9-A2E0-19B44783A5A4Q35125797-E16AEEE6-552A-480C-8B32-E7E11B4FA4CAQ35132969-BDDA883D-F2E8-428A-9E2B-78CE4CA99538Q35133558-D2ACDA7A-A9DE-4D11-9A58-17558B1C628D
P2860
Novel plasmid-mediated beta-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy beta-lactams in clinical isolates of Klebsiella pneumoniae
description
1990 nî lūn-bûn
@nan
1990 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Novel plasmid-mediated beta-la ...... lates of Klebsiella pneumoniae
@ast
Novel plasmid-mediated beta-la ...... lates of Klebsiella pneumoniae
@en
Novel plasmid-mediated beta-la ...... lates of Klebsiella pneumoniae
@nl
type
label
Novel plasmid-mediated beta-la ...... lates of Klebsiella pneumoniae
@ast
Novel plasmid-mediated beta-la ...... lates of Klebsiella pneumoniae
@en
Novel plasmid-mediated beta-la ...... lates of Klebsiella pneumoniae
@nl
prefLabel
Novel plasmid-mediated beta-la ...... lates of Klebsiella pneumoniae
@ast
Novel plasmid-mediated beta-la ...... lates of Klebsiella pneumoniae
@en
Novel plasmid-mediated beta-la ...... lates of Klebsiella pneumoniae
@nl
P2093
P2860
P3181
P356
P1476
Novel plasmid-mediated beta-la ...... lates of Klebsiella pneumoniae
@en
P2093
A A Medeiros
G A Jacoby
G A Papanicolaou
P2860
P304
P3181
P356
10.1128/AAC.34.11.2200
P407
P577
1990-11-01T00:00:00Z